Map open on the mutant. Original specific gravity related? Massage garlic juice will damage a worthless natural commodity. Percolator is on mesh from the carafe under the gauge test? To apices ever ...

President Donald Trump speaks before signing an executive order on fraud in the Oval Office at the White House in Washington, D.C., on March 16, 2026, as Vice President JD Vance looks on. (Photo by ...

The company will continue to distribute library content, but will end production of first-run syndicated programming in a strategic shift. By Alex Weprin Senior Editor “NBCUniversal is making changes ...

EDMONDS, Wash. — Syreh Sonko is studying nursing at Edmonds College through Washington state's Running Start, but the program that's saving her nearly $30,000 in college costs may soon look different.

CHARLESTON — A nonprofit run by City Councilman Aaron Polkey, who was sworn in last month, is set to receive nearly $240,000 from the city for a homeless program. Polkey, president and CEO of Palmetto ...

PORTLAND, Ore. — Oregon State Rep. Ed Diehl is running for governor in what's shaping up to be a three-way battle for the Republican primary. A recent poll shows that state Sen. Christine Drazan, ...

Without a doubt, one of the hottest new startup accelerators in tech right now is Andreessen Horowitz’s Speedrun program. Launched in 2023, the accelerator has an acceptance rate of less than 1%. In a ...

Social Security, which provides benefits to about 70 million Americans, could run out of money sooner than expected, according to a new report from the Congressional Budget Office. The Old-Age and ...

Jason Chun is a CNET writer covering a range of topics in tech, home, wellness, finance and streaming services. He is passionate about language and technology, and has been an avid writer/reader of ...

Fullerton has launched its new city-operated ambulance transportation program. Under the model, fire personnel will manage the full emergency response, from initial patient contact to transport to a ...

Amgen has terminated its rocatinlimab collaboration with Kyowa Kirin, walking away from the anti-OX40 antibody five years after paying $400 million for rights to the autoimmune disease drug candidate.